Novartis Ag (NVS) Non Operating Investment Income (2010 - 2018)
Novartis Ag recorded quarterly Non Operating Investment Income of -$177.0 million in Q2 2018, down 165420660.75% quarter-over-quarter from $107.0 in Q3 2012.
Novartis Ag's Non Operating Investment Income history runs 4 years deep, the most recent figure standing at -$177.0 million for Q2 2018.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | - |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | - |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | - |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | - |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | - |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | - |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | - |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | - |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2018 | -177.00 Mn |
| Jun 30, 2018 | -177.00 Mn |
| Sep 30, 2012 | 107.00 |
| Sep 30, 2012 | 107.00 |
| Mar 31, 2012 | 15.00 |
| Mar 31, 2012 | 15.00 |
| Dec 31, 2011 | -11.00 |
| Dec 31, 2011 | -11.00 |
| Sep 30, 2011 | -10.00 |
| Sep 30, 2011 | -10.00 |
| Jun 30, 2011 | 239.00 |
| Jun 30, 2011 | 239.00 |
| Dec 31, 2010 | -190.00 |
| Dec 31, 2010 | -190.00 |
| Mar 31, 2010 | -319.00 |
| Mar 31, 2010 | -319.00 |